These results suggested that mRNA expressions of HLA-DPB2 and HLA-DPB1 were independent prognostic factors for OS of BC patients and that HLA-DPB2 expression in BC may have an anticancer effect in BC by regulating the expression of its parental gene, HLA-DPB1. This evidence concerns the gene HLA-DPB2 and breast cancer.